Published in Cancer on November 01, 1966
Adoptive T cell therapy for cancer in the clinic. J Clin Invest (2007) 3.45
Principles of adoptive T cell cancer therapy. J Clin Invest (2007) 2.65
Cancer therapy with bispecific antibodies: Clinical experience. Curr Opin Mol Ther (2010) 1.26
Tumour-distinctive cellular immunity to renal carcinoma. Clin Exp Immunol (1970) 1.03
Histological evidence of tumour rejection after active immunotherapy in human malignant disease. Br Med J (1972) 0.81
Tumor immunity. An overview. Am J Pathol (1978) 0.75
Stem cells in gastrointestinal cancers. Dis Markers (2008) 0.75
Current treatment options of T cell-associated immunotherapy in multiple myeloma. Clin Exp Med (2017) 0.75
POSTOPERATIVE NITROGEN LOSS AND STUDIES ON PARENTERAL NITROGEN NUTRITION BY MEANS OF CASEIN DIGEST. Ann Surg (1942) 6.94
The Surgical Treatment of Carcinoma of the Body of the Pancreas. Ann Surg (1944) 3.48
Osteogenic sarcoma under the age of twenty-one. A review of one hundred and forty-five operative cases. J Bone Joint Surg Am (1970) 1.77
Virus biographies. II. Growth of herpes simplex virus in tissue culture. Exp Mol Pathol (1967) 1.70
Whither gynecology? Am J Obstet Gynecol (1968) 1.42
Radical Resections of Advanced Intra-abdominal Cancer: Summary of Results in 100 Patients. Ann Surg (1945) 1.33
Hepatitis B antigen, antigen subtypes, and hepatitis B antibody in normal subjects and patients with liver disease. Bull World Health Organ (1975) 1.29
Deperitonealization: Clinical and Experimental Observations. Ann Surg (1949) 1.28
The immunologic status of patients with nonlymphomatous cancer. Cancer Res (1968) 1.25
Evidence of immunological reactions to autochthonous cancer in man. Eur J Cancer (1965) 1.23
WOUND HEALING AND NEOPLASIA: AN EXPERIMENTAL INVESTIGATION. Ann Surg (1937) 1.19
Semliki Forest virus in HEp-2 cell cultures. J Virol (1967) 1.09
Phagocytic activity of the reticuloendothelial system in neoplastic disease. J Lab Clin Med (1967) 1.07
Inhibition of herpes simplex virus by synthetic double-stranded RNA (polyriboadenylic and polyribouridylic acids and polyriboinosinic and polyribocytidylic acids). Proc Natl Acad Sci U S A (1969) 1.04
Stable cell line of rat nephroma in tissue culture. Proc Soc Exp Biol Med (1967) 1.03
Serum levels of second component of complement in cancer patients. J Immunol (1966) 0.99
Excision of major blood vessels at the periphery of the pelvis in patients receiving pelvic exenteration: common and/or iliac arteries and veins 1947 to 1964. Surgery (1967) 0.97
Cytotoxicity of sera from healthy persons and cancer patients. Int J Cancer (1969) 0.97
Pelvic exenteration for locally advanced and recurrent ovarian cancer. Review of 22 cases. Surgery (1965) 0.96
Host resistance to cancer. Clinical experiments by homotransplants, autotransplants and admixture of autologous leucocytes. Ann Surg (1965) 0.96
What are the indications and results of pelvic exenteration? JAMA (1965) 0.96
Growth of human cancer cells in interscapular brown fat of rats. Transplantation (1968) 0.95
Pelvic exenteration for advanced cancer of the colon. Bull Soc Int Chir (1969) 0.94
Enhancement of responses to chemical carcinogens by nononcogenic viruses and antimetabolites. Prog Exp Tumor Res (1969) 0.93
Complete Excision of Pelvic Viscera in the Male for Advanced Carcinoma of the Sigmoid Invading the Urinary Bladder. Ann Surg (1949) 0.92
Lymphocyte transfer tests in cancer patients and healthy people. Cancer (1968) 0.91
Advanced Carcinoma of the Extrahepatic Bile Ducts: Choleangiocholecystocholedochectomy. Ann Surg (1945) 0.90
Evidence of common antigenic properties in chemically induced sarcomas of mice. Cancer Res (1967) 0.90
Standards for selected anthropometric measurements in males with the fragile X syndrome. Pediatrics (1992) 0.89
Effect of immunosuppression on first-generation isotransplantation of chemically induced tumours in mice. Nature (1966) 0.88
Further evidence of common antigenic properties in chemically induced sarcomas of mice. Cancer Res (1969) 0.87
Definitive treatment of radiation necrosis. 5-year results in 77 patients. Obstet Gynecol (1970) 0.86
Rejection of human cancer transplants by tolerant rats following treatment with allogenic lymphoid cells. Cancer Res (1969) 0.86
Intravenous Gelatin. Ann Surg (1943) 0.85
Diffusible cytotoxic substances and cell-mediated resistance to syngeneic tumors: in vitro demonstration. Science (1968) 0.85
A GASTRIC SECRETORY DEPRESSANT IN EXTRACTS OF ACHLORHYDRIC CARCINOMATOUS STOMACHS. Ann Surg (1941) 0.83
Secondary and tertiary rediversion of the urinary tract. A study based upon 72 cases among 840 pelvic exenterations for advanced cancer. JAMA (1968) 0.83
Urinary tract fistulas following pelvic exenteration. Obstet Gynecol (1966) 0.83
Resection of Abdominal Carcinomas Involving the Liver and Spleen Secondarily. Ann Surg (1946) 0.83
Obstructive uropathy in laboratory mice. Proc Soc Exp Biol Med (1965) 0.82
Proceedings: Clinical trial of autogenous tumor vaccine for treatment of osteogenic sarcoma. Proc Natl Cancer Conf (1972) 0.82
Incidence of carcinoma in the retained ovary. Am J Surg (1967) 0.82
Production of 19S and 7S antibodies by cancer patients. Clin Exp Immunol (1970) 0.82
Late second cancers of the cervix after apparently successful initial radiation therapy. Am J Roentgenol Radium Ther Nucl Med (1970) 0.82
Tumor-specific, cell-mediated immune resistance to autochthonous tumors. Cancer Res (1972) 0.82
Hetero- transplantation of human cell lines from Burkitt's tumors and acute leukemia into newborn rats. Cancer (1969) 0.81
Multiple cases of Burkitt's lymphoma and other neoplasms in families in the North Mara District of Tanzania. Int J Cancer (1980) 0.81
Evidence for cancer-specific angigens in man. Prog Exp Tumor Res (1967) 0.81
A clinical trial of autogenous vaccine in osteogenic sarcoma in patients under the age of twenty-five. Surg Forum (1971) 0.80
Pelvic exenteration combined with resection of segments of bony pelvis. Surgery (1969) 0.80
Co-existence of allogeneic tumour growth and homograft immunity in man. Eur J Cancer (1968) 0.80
Operative management of patients previously operated upon for a benign lesion with cervical cancer as a suprise finding. Am J Obstet Gynecol (1968) 0.79
Osteogenic sarcoma in childhood. N Y State J Med (1971) 0.79
In vitro immunological studies on east african cancer patients. III. Spontaneous rosette formation by cells from Burkitt lymphoma biopsies. Int J Cancer (1975) 0.79
Induction of subcutaneous tumors in rats by plastic loops and spirals. Am J Obstet Gynecol (1966) 0.79
A bank of frozen peripheral blood lymphocytes for in vitro immunological studies on East African cancer patients. Int J Cancer (1974) 0.79
Increased growth of tumor isotransplants after immunosuppression of the recipient mice by methotrexate or 5-fluoro-2'-deoxyuridine. J Natl Cancer Inst (1967) 0.78
Unusual membrane formations in HEp-2 cells infected with Ilheus virus. Lab Invest (1973) 0.78
The prevalence of antibodies to human T-lymphotropic virus type I in different population groups in Papua New Guinea. Arch Virol (1993) 0.78
Vaccine trials for osteogenic sarcoma. A preliminary report. CA Cancer J Clin (1973) 0.78
Use of an indirect antiglobulin consumption test to detect isoantibodies following human cancer cell homotransplants. Eur J Cancer (1966) 0.78
A quantitative Rebuck technic. Blood (1966) 0.78
DNA sequence of a simian varicella virus gene that encodes a homologue of varicella zoster virus IE62 and herpes simplex virus ICP4. Virology (1993) 0.78
Emotions, immunology, and cancer: how might the psyche influence neoplasia? Ann N Y Acad Sci (1969) 0.77
The surgical treatment of cancer of the cervix: stage I and II. Am J Roentgenol Radium Ther Nucl Med (1968) 0.77
Surgical treatment of squamous-cell carcinoma of the vulva. Obstet Gynecol (1967) 0.77
THE EFFICACY OF "COLEY'S TOXIN" IN THE TREATMENT OF SARCOMA: AN EXPERIMENTAL STUDY. Ann Surg (1939) 0.77
A study of cellular responses in cancer patients by qualitative and quantitative Rebuck tests. Surg Forum (1965) 0.76
Ethnic-group differences in serum levels of carcinoembryonic antigen. Lancet (1979) 0.76
Xenotransplantation of a Burkitt lymphoma culture line with surface immunoglobulin specificity. Nature (1969) 0.76
Resection of head of pancreas and duodenum for carcinoma--pancreatoduodenectomy. CA Cancer J Clin (1975) 0.76
Experiences in the Surgical Treatment of Multiple Visceral Neoplasms. Ann Surg (1947) 0.75
HLA antigens in East African Black patients with Burkitt's lymphoma or nasopharyngeal carcinoma and in controls: a pilot study. Hum Immunol (1982) 0.75
What are the possibilities for immunotherapy and immunoprophylaxis of cancer? Clin Pharmacol Ther (1968) 0.75
Medical oncology. Lancet (1971) 0.75
Immunologic tolerance to human cancer transplants in rats. Cancer Res (1966) 0.75
Potentiating effect of thalidomide on methylcholanthrene oncogenesis in mice. Experientia (1970) 0.75
Immunogenic efficacy of various syngeneic tumor cell preparations. Cancer (1971) 0.75
Zoster-like lesions from herpes simplex virus in newborn rats. Proc Soc Exp Biol Med (1965) 0.75
Analysis of cell-mediated immune reactions to syngeneic mouse tumors in tissue culture. Acta Pathol Jpn (1969) 0.75
Cell-mediated tumor specific immune reactions: in vitro demonstration. Gan (1970) 0.75
The role of radiation therapy (including isotopes) in the treatment of cancer of the ovary (results of 614 patients treated at Memorial Hospital, New York, N.Y.). Prog Clin Cancer (1973) 0.75
Heterotransplantability of human cell lines derived from leukemia and lymphomas into immunologically tolerant rats. Cancer (1969) 0.75
Growth of primary explants of human cancer in newborn rats. Cancer (1966) 0.75
Treatment of cancer of the cervix, all stages, by surgical excision. Proc Natl Cancer Conf (1970) 0.75
["Pelvic exenteration". Indications, techniques, results. 1953]. Ann Chir (1997) 0.75
A Dermoid of the Cornea in a Guinea Pig. Am J Pathol (1928) 0.75
Influence of thymectomy on growth of human cell xenografts in newborn rats. Transplantation (1969) 0.75
Immunopathology of cancer. Introductory remarks. Fed Proc (1966) 0.75
Diffusible Cytotoxic Substances and Cell-Mediated Resistance to Syngeneic Tumors: In vitro Demonstration. Science (1969) 0.75